Famotidine 63323-0738-09
- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 19, 2001
- Listing Expires
- December 31, 2026
- Application
- ANDA075709
Need to source Famotidine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Famotidine | 10 mg/mL |
Drug Class
Histamine-2 Receptor Antagonist [EPC]Histamine H2 Receptor Antagonists [MoA]Histamine-2 Receptor Antagonist [EPC]
Selected Package
63323-0738-09Selected10 VIAL, MULTI-DOSE in 1 TRAY (63323-738-09) / 4 mL in 1 VIAL, MULTI-DOSE (63323-738-03)
Other packages for this product(1)
10 VIAL, MULTI-DOSE in 1 TRAY (63323-738-20) / 20 mL in 1 VIAL, MULTI-DOSE (63323-738-06)